Novo Nordisk has partnered with Aspen to produce insulin for Africa, but critics say it fails to address the shortage of insulin pens in SA’s public hospitals.
Insulin deal faces criticism over lack of insulin pens
Original Article by Christina Pitt | Bhekisisa Centre for Health Journalism | 16 August 2025
Novo Nordisk has partnered with Aspen to produce insulin for Africa, but critics say it fails to address the shortage of insulin pens in SA's public hospitals.
More Posts
Mpox Cases in SA Rise as Local Transmission Accelerates
Mpox cases in South Africa are rising, mainly in the Western Cape. What the surge means for the healthcare industry.
Read more...
NHLS Scrambles as Pathology Services Funding Runs Dry
The NHLS is scrambling for new providers after funds for haematology pathology services ran dry, amid an R11.3bn provincial debt
Read more...
Momentum Group Posts Record Earnings
Momentum Group has posted record earnings, with normalised headline earnings up 13% to R7.06bn – beating its R7bn Impact target a year early.
Read more...